Skip to main content
OpenTrials
Completed

NCT Number: NCT03496844

Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma

Determine diagnostic accuracy of Axumin-PET positive bone lesion by confirmatory bone biopsy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostate Adenocarcinoma

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

University of Arizona

Tucson, Arizona, 85724, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male
  • Be ≥ 18 years of age
  • Diagnosed with prostate cancer
  • Be willing and able to provide informed consent
  • Be informed of the investigational nature of this study

Exclusion criteria

  • Having a history of severe claustrophobia
  • Weight exceeding 400lbs

Treatment and study plan

F-18 fluciclovine-PET/CT scan

Diagnostic Test

PET/CT imaging with F-18 fluciclovine

Other names: Axumin-PET scan

Primary outcomes

  1. True Positive and False Positive Rates of F-18 Fluciclovine-PET/CT Findings Compared to Bone Biopsy

    Time frame: 1 year

    True positive and false positive rates of positive findings in the skeleton on F-18 fluciclovine-PET/CT scan compared to gold standard pathology from bone biopsy

Sponsors and collaborators

Lead sponsor

University of Arizona

Other

Collaborators

  • Banner University Medical Center
  • Blue Earth Diagnostics

Registry information

Official study title

A Pilot Study of F-18 Fluciclovine-PET/CT as A Diagnostic Tool for Bone Metastases in Patients With Hormonal Sensitive and Resistant Prostate Adenocarcinoma

Acronym: BoneMetPETCT

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Apr 12, 2018
Registry last updated
Aug 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.